Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Impax Laboratories buys Tower Holdings and Lineage for $700mm

Executive Summary

Impax Laboratories Inc. (drug delivery technology for controlled-release and niche generics, and branded products) paid $700mm for privately held Tower Holdings Inc., which operates through CorePharma LLC and Amedra Pharmaceuticals LLC, and closely held Lineage Therapeutics Inc. PE firm RoundTable Healthcare Partners previously owned both Tower and Lineage.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies